Barbara Slusher
Physician Assistant · Manning, SCNPI 1417982984
Payments from drug & device makers
Across 161 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$969
- Johnson & Johnson$531
- Amgen$275
- Sandoz$272
- Novartis$171
- UCB, Inc.$161
- plus $469 from 9 others
What the payments were for
- Food & beverage$2,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $969 |
| Johnson & Johnson | 28 | $531 |
| Amgen | 18 | $275 |
| Sandoz | 13 | $272 |
| Novartis | 8 | $171 |
| UCB, Inc. | 7 | $161 |
| GSK | 24 | $156 |
| AstraZeneca(2 entities) | 7 | $133 |
| Tonix Medicines, Inc. | 1 | $43 |
| Pfizer | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Medtronic | 1 | $15 |
How this compares
$2,846 in reported general payments places this provider in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 61 | $528,932 |
| RinvoqUpadacitinib | 43 | $304,240 |
| Orencia ClickjectAbatacept | 24 | $176,360 |
| Humira(Cf)Adalimumab | 19 | $143,201 |
| Taltz AutoinjectorIxekizumab | 18 | $136,820 |
| Enbrel SureclickEtanercept | 11 | $116,158 |
| Xeljanz XrTofacitinib Citrate | 18 | $101,048 |
| BenlystaBelimumab | 15 | $80,938 |
| Hydroxychloroquine Sulfate | 265 | $12,040 |
| Diclofenac Sodium | 75 | $5,176 |
| MethotrexateMethotrexate Sodium | 168 | $3,538 |
| Doxycycline Hyclate | 100 | $2,596 |
| Celecoxib | 40 | $1,986 |
| Mycophenolate Mofetil | 28 | $1,710 |
| Leflunomide | 42 | $1,417 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Humira(Cf) | $969 | $447,44262 claims |
| GSKBenlysta | $156 | $80,93815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Manning
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.